Cognitive Assessment and Brain Health Market Size, Share and Trends 2026 to 2035

Cognitive Assessment and Brain Health Market Size and Forecast 2026 to 2035

The global cognitive assessment and brain health market size accounted for USD 9.40 billion in 2025 and is predicted to increase from USD 10.51 billion in 2026 to approximately USD 28.69 billion by 2035, expanding at a CAGR of 11.80% from 2026 to 2035. Rising neurological disease prevalence, growing awareness, and improved diagnosis are key factors driving growth in the market.

Key Takeaways

• North America led the cognitive assessment and brain health market with a share of 40% in 2025.
• Asia-Pacific is expected to be the fastest-growing region with a CAGR of 14.5% in the forecasted duration.
• By component, the assessment software segment held a dominant position in the market with a share of 38% in 2025.
• By component, the brain training solutions segment is expected to grow at the fastest CAGR of 13.5% in the market between 2026 and 2035.
• By assessment type, the cognitive assessment segment accounted for a considerable revenue share of 34% in the market in 2025.
• By assessment type, the memory assessment segment is expected to grow with the highest CAGR of 12.7% in the market during the studied years.
• By application, the Alzheimer's disease and dementia management segment led the global cognitive assessment and brain health market with a share of 31% in 2025.
• By application, the clinical research segment is expected to expand rapidly in the market with a CAGR of 13.7% in the coming years.
• By end user, the hospitals and clinics segment registered its dominance over the global market with a share of 42% in 2025.
• By end user, the homecare settings segment is expected to witness the fastest growth in the market with a CAGR of 15% over the forecast period.
• By technology, the digital cognitive assessment platforms segment dominated the global market with a share of 46% in 2025.
• By technology, the AI-based cognitive analytics segment is expected to witness the fastest growth in the market with a CAGR of 17.2% over the forecast period.

Market Overview

Cognitive assessments are a series of tests, such as questionnaires and tasks, used to evaluate an individual's brain health in a systematic way. These assessments usually consist of answering simple questions and doing simple tasks. Brain health is defined by the World Health Organization (WHO) as the optimal functioning of the cognitive, sensory, social-emotional, behavioral, and motor domains that allows individuals to reach their full potential throughout life, even with pre-existing disorders. Early diagnosis of brain-related concerns is very important as it provides patients with maximum benefits from the existing treatment options. Further, the market growth is substantially driven by the growing awareness of neural health.

Impact of Artificial Intelligence on the Cognitive Assessment and Brain Health Industry

Artificial Intelligence (AI) aids healthcare professionals in diagnosing diseases and creating new treatments and innovations. AI has shown promise in cognitive assessment and in supporting medical practice by allowing more precise analysis of large volumes of clinical data to accurately assess brain health. AI can enhance the quality of care by optimizing data collection and analysis, personalizing treatments, monitoring patients, prioritizing tasks, and automating documentation. It also enables early identification of cognitive impairment and the delivery of individualized interventions.

Cognitive Assessment and Brain Health Market Trends

• AI-Enabled Remote Cognitive Assessment: The frontier of brain health monitoring is being pushed by cognitive assessment solutions using smartwatches and smartphones, which allow for continuous evaluation of cognitive and functional status in real-world environments via frequent, ecologically relevant digital measurements.
• Multimodal Early Detection of Cognitive Decline: The use of AI-powered cognitive tests, blood tests for biomarkers, and MRI brain scans is improving the ability to detect Alzheimer's disease and other memory problems in adults 50 and older, earlier and more accurately.
• Neuromodulation-Integrated Cognitive Assessment: Neuromodulation technologies are being integrated into next-generation cognitive assessment platforms to assess brain plasticity and reactivity, offering a more granular view into neural resilience and system-level cognition.

Market Report Coverage and Key Metrics

Market Dynamics

Drivers

AI-Driven Cognitive Assessments

Rising neurological disorders and mental health awareness are boosting demand for cognitive assessments. Healthcare providers are adopting AI-based systems to enhance diagnostic accuracy, enable earlier detection, and personalize treatment. Growing awareness of brain health among consumers and clinicians across care settings is further accelerating market growth.

Restraint

Data Security Risks and High Costs

Expanding digital healthcare raises major data security and privacy concerns around handling sensitive patient information and meeting regulatory standards. Additionally, high subscription and licensing costs for digital cognitive assessment platforms, especially in low- and middle-income countries, restrict widespread adoption and constrain market growth.

Opportunity

Next-Gen Cognitive Assessments Enable Personalized Brain Health

Rising neurological disorders and personalized care needs are driving demand for next-generation cognitive assessments. As vital tools for early brain health evaluation and treatment planning, these solutions emphasize precision, patient-centricity, and advanced technologies to enhance personalized care, diagnostic accuracy, and clinical outcomes.

Market Segmentation Analysis

Component Insights

The Assessment Software Segment Dominated the Market with 38% of Market Share in 2025

The assessment software segment dominated the cognitive assessment and brain health market with a 38% share in 2025, driven by rising demand for digital cognitive testing and growing telehealth adoption. Digital cognitive assessment software leverages familiar digital devices to streamline test administration while enhancing the clinical insights available to providers. Furthermore, the expansion of cloud-based healthcare platforms is promoting segment growth.

The assessment services segment secured 27% of the market share in 2025 and is expected to grow at a CAGR of 9.8% during the forecast period, supported by growing demand for specialist evaluations and increasing neurological consultations. Moreover, the expansion of memory clinics and rising mental health screening needs are further contributing to segment growth.

The brain training solutions segment captured 14% of the market share in 2025 and is expected to be the fastest-growing segment, with a CAGR of 13.5% in the coming years, due to a growing focus on cognitive wellness and increasing consumer awareness of brain fitness. Brain training solutions are valuable tools for managing various conditions, whether recovering from an injury, managing a chronic illness, or addressing age-related cognitive decline. Brain training programs can offer specific benefits. In addition, the expansion of mobile health applications is supporting the growth of this segment.

Assessment Type Insights

The Cognitive Assessment Segment Led the Market with 34% Share in 2025

The cognitive assessment segment led the cognitive assessment and brain health market with a 34% share in 2025, driven by the rising demand for early detection of cognitive impairments and the increasing adoption of routine neurological screenings. This assessment is expertly structured to evaluate brain function, and its dominance is further bolstered by the growing trend of digital assessments.

The neuropsychological assessment segment captured 24% of the market share in 2025 and is expected to grow at a robust CAGR of 10.4% in the coming years, driven by an uptick in mental health evaluations. Neuropsychological testing encompasses a series of assessments used by healthcare providers to understand brain functionality. The rise in diagnosed neurological disorders and heightened clinical research activities are key factors propelling market growth.

The memory assessment segment accounted for 18% of the market share in 2025 and is expected to be the fastest-growing segment with a CAGR of 12.7% from 2026 to 2035, due to the increasing demand for Alzheimer's screenings and the expanding aging population. Tailored for patients exhibiting symptoms of dementia, this segment's growth is supported by the rising prevalence of dementia and the growing utilization of memory clinics.

Application Insights

The Alzheimer's Disease and Dementia Management Segment Dominated the Market with 31% Share in 2025

The Alzheimer's disease and dementia management segment held the largest revenue share of 31% in the cognitive assessment and brain health market in 2025, driven by the escalating global burden of dementia and a heightened emphasis on early diagnosis. The growth of cognitive screening initiatives and increased pharmaceutical research efforts further solidifies this segment's dominance.

Cognitive Assessment and Brain Health Market Share, By Application, 2025-2035 (%)

The traumatic brain injury (TBI) assessment segment captured 17% of the market share in 2025 and is expected to experience a robust CAGR of 10.6% in the forthcoming years. This growth is primarily driven by the rising demand for monitoring sports-related injuries and the expanding applications within military healthcare. Additionally, the uptick in emergency neurological assessments and advancements in neurodiagnostic technologies contribute to this positive trend.

The clinical research segment accounted for 14% of the market share in 2025 and is projected to emerge as the fastest-growing segment, with a CAGR of 13.7% in the years ahead. This growth can be attributed to the increasing number of neurological clinical trials and a surge in biomarker research. Furthermore, the growing investment in CNS drug development and the integration of digital endpoints in trials are enhancing adoption rates.

End User Insights

The Hospitals and Clinics Segment Dominated the Market with a 42% Share in 2025

The hospitals and clinics segment dominated the cognitive assessment and brain health market with a share of 42% in 2025, due to the rising number of neurological patients and the expansion of cognitive screening programs. Additionally, the increasing adoption of digital diagnostics, heightened healthcare investments, and the demand for clinical decision support are further solidifying this segment's market leadership.

Cognitive Assessment and Brain Health Market Share, By End User, 2025-2035 (%)

The academic and research Institutes segment captured 18% of the market share in 2025 and is expected to experience a CAGR of 10.9% in the coming years, driven by an uptick in neuroscience research activities and greater availability of grant funding. Furthermore, the expansion of cognitive health studies, increased academic collaborations, and the development of innovative assessment tools are propelling this segment forward.

The homecare settings segment achieved 14% of the market share in 2025 and is expected to expand rapidly with a CAGR of 15% in the upcoming years, driven by the growing adoption of remote patient monitoring and the expansion of telehealth services. Additionally, the rising demand for home care among the elderly, increased penetration of digital health platforms, and the need for convenient assessment solutions are driving this segment's growth.

Technology Insights

The Digital Cognitive Assessment Platforms Segment Dominated the Market with a 46% Share in 2025

The digital cognitive assessment platforms segment dominated the cognitive assessment and brain health market with a 46% share in 2025, driven by the growing demand for remote assessments and the expansion of cloud-based healthcare systems. These platforms provide scientifically validated, precise, and objective measures of cognitive function. Furthermore, increasing patient accessibility, along with improved scalability and efficiency, is supporting segment growth.

The AI-based cognitive analytics segment captured 19% of the market share in 2025 and is expected to grow at the highest CAGR of 17.2% during 2026-2035, due to increasing AI integration in healthcare and the rising demand for predictive analytics. AI-based cognitive analytics offer significant potential to enhance decision-making, optimize performance, and create new avenues for value creation. Moreover, improved diagnostic accuracy and the expansion of personalized medicine are further supporting growth.

The neuroimaging-based assessment segment accounted for 23% of the market share in 2025 and is expected to grow at a CAGR of 8.9% in the coming years, driven by increasing demand for neurological diagnostics and the expansion of advanced imaging technologies. Neuroimaging-based brain-age estimation has been increasingly applied to individuals with various neuropsychiatric disorders and to the general population. Rising research applications are further supporting the growth of this segment.

Market Regional Analysis: North America, Europe, Asia-Pacific

U.S. Cognitive Assessment and Brain Health Market Size and Growth 2026 to 2035

The U.S. cognitive assessment and brain health market size was evaluated at USD 2.82 billion in 2025 and is projected to reach around USD 7.72 billion by 2035, growing at a CAGR of 10.62% from 2026 to 2035.

North America: Dominated with 40% share in 2025

North America held a major revenue share of 40% in the cognitive assessment and brain health market in 2025, driven by the growing prevalence of dementia and cognitive disorders and the strong adoption of digital health technologies. Furthermore, high healthcare expenditure levels, the expansion of remote cognitive assessment programs, and increasing neurological research funding are supporting market growth.

U.S. Market Analysis

The U.S. is at the forefront of the North American market, supported by initiatives that provide secure, supportive meetings for mental wellness. Moreover, its cognitive assessment solutions deliver personalized care, while flexible online sessions bring compassionate, professional care directly to patients.

Which Factors Drive the Cognitive Assessment and Brain Health Market in Asia-Pacific?

Asia-Pacific held 22% of the market share in 2025 and is expected to experience the fastest growth with a CAGR of 14.5% during the predicted timeframe, driven by rapid healthcare digitization and an increasing neurological disease burden. Moreover, the expansion of telehealth and digital assessment platforms is further propelling regional growth.

China Market Analysis

China is at the forefront of the Asia-Pacific market. The country is increasingly capable of developing original, innovative drugs and taking the initiative in personalized treatment for brain health. Moreover, the Chinese Institute for Brain Research (CIBR) supports cognitive brain health services by helping high‑risk groups assess lifestyle‑related dementia risks.

Europe: The Second-Largest Region

Europe held the second-largest market share of 28% in 2025 and is expected to grow at a notable CAGR of 10.9% in the foreseeable future, supported by an aging population and rising awareness of brain health monitoring. The European Partnership for Brain Health (EP BrainHealth) is a major initiative across Europe. Launched in January 2026, it is one of the greatest collaborative efforts in brain research worldwide and supports the market.

Germany Market Analysis

Germany is thriving in the European market, supported by the expansion of cognitive screening initiatives and the increasing adoption of digital diagnostics. Furthermore, growing government initiatives and programs led by the German Center for Neurodegenerative Diseases are reinforcing market growth.

Will the Middle East and Africa Grow in the Cognitive Assessment and Brain Health Market?

The Middle East and Africa region accounted for 4% of the market share in 2025 and is expected to grow at a CAGR of 11.2% in the coming years, driven by improving healthcare infrastructure and growing awareness of neurological health. Moreover, the expansion of digital healthcare initiatives, increasing government healthcare investments, and the rising prevalence of chronic neurological conditions are supporting growth.

UAE Market Analysis

The UAE is witnessing significant market growth, driven by various government initiatives for brain health. The region is focusing on the Center for Brain and Health's goal to advance the understanding of brain function in health and disease, with particular emphasis on disorders prevalent in the UAE.

How is Latin America Growing in the Cognitive Assessment and Brain Health Market?

Latin America held 6% of the market share in 2025 and is expected to grow at a considerable CAGR of 10.8% in the upcoming period, supported by the growing adoption of digital health solutions and increasing mental health awareness. Moreover, the expansion of healthcare access programs and the rising demand for cognitive screening are further contributing to regional market growth.

Brazil Market Analysis

Brazil is performing well in the Latin American market, driven by improving neurological care services. Furthermore, the region continues to invest in interdisciplinary research, public education, and equitable access to care to promote healthier aging and a better quality of life, thereby supporting the adoption of cognitive assessment and brain health initiatives.

Market Competitive Landscape: Leading Companies and Strategies

The cognitive assessment and brain health market is semi-consolidated, featuring players who offer structured assessments and utilize standardized protocols like the Wechsler Adult Intelligence Scale (WAIS) for result analysis. Additionally, several companies are innovating in software development, providing highly accurate digital cognitive assessments that are utilized worldwide in both research and clinical settings. They also manage digitized endpoints for commercial clinical trials in collaboration with various organizations.

However, the market faces significant challenges, including rising cybercrime, fragmented reimbursement policies, strict regulatory requirements, and limited adoption by primary care providers. Despite these obstacles, companies are actively innovating to create mobile-first, FDA-authorized platforms tailored for swift screening in primary care environments and senior living facilities. These solutions combine digital cognitive assessments with behavioral health interventions, all delivered through mobile channels.

Top Companies in the Cognitive Assessment and Brain Health Market

• Cogstate
• Cambridge Cognition
• Pearson
• BrainCheck
• Posit Science
• Lumos Labs
• CNS Vital Signs
• Neurotrack
• Altoida
• Creyos
• BrainScope
• EMOTIV
• Muse
• Nexalin Technology
• Neuroelectrics

Segments Covered in the Report

By Component

• Assessment Software
• Assessment Services
• Brain Monitoring Devices
• Brain Training Solutions

By Assessment Type

• Cognitive Assessment
• Neuropsychological Assessment
• Memory Assessment
• Attention and Executive Function Assessment
• Others

By Application

• Alzheimer's Disease and Dementia Management
• Traumatic Brain Injury (TBI) Assessment
• Mental Health Assessment
• Academic and Educational Assessment
• Clinical Research
• Others

By End User

• Hospitals and Clinics
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Homecare Settings
• Others

By Technology

• Digital Cognitive Assessment Platforms
• AI-Based Cognitive Analytics
• Neuroimaging-Based Assessment
• Wearable Brain Monitoring Technologies

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa